Latest from Business Reports

Mood of the Boardroom: A Covid caveat for business

Latest lockdown has made forecasting uncertain for some of NZ's biggest firms.

Tribute: Michael Cullen KNZM (1945-2021)

Sir Michael Cullen was blessed with a sharp intellect and quick wit.

Thomas Pippos: Letting the sleeping tax dogs lie

COMMENT: Business leaders wedge the Government between a rock and a hard place on tax.

Mood of the Boardroom: Miles Hurrell - 'We need to be one step ahead of the rest'

New Zealand has an unique farming system with the pasture-based free roaming cows.

Mood of the Boardroom: Offshore recruiters raise the bar

NZ companies have been impacted by Australian and UK recruiters targeting Kiwis.

Mood of the Boardroom: Inflation 'beast' on the loose

What do CEOs think about the biggest increase in consumer prices in nearly a decade?

Wage and salary packages set to rise

Salaries at the top end are up due to a shortage in the labour market.

Mood of the Boardroom: The reconnecting question

CEOs are divided on whether a firm date should be set to open up the border.

Mood of the Boardroom: Covid blows NZ into rocky waters

Parts of our plan for reconnecting to the world need to be turbo-charged.

Mood of the Boardroom: Housing needs an urgent fix

Land supply seen as one of the biggest hurdles.

Mood of the Boardroom: Technology — a godsend under Covid

Even "drinks" after work to keep staff morale up at week's end.

Mood of the Boardroom: Why methane emissions are a touchy subject

Agriculture will not be included in the Emissions Trading Scheme (ETS) until 2025.

Mood of the Boardroom: Top issues facing the nation

The Herald asked survey respondents what they saw as the top issues facing the nation.

Cathy Quinn: Balance is key to fraught climate-change debate

COMMENT: Every business I am involved with is aware of the need to reduce emissions.

Mood of the Boardroom: Government has the big calls right

Addressing educational standards should be an urgent priority for New Zealand.

Top issues facing the nation: CEOs have their say

The rest of us want to get in. Order more vaccines beyond Pfizer.